Click Chemistry Coating for Cellular Integration
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current implantable medical devices often fail to fully integrate with tissue due to poor cell seeding, leading to issues such as discomfort, tissue weakening, and interference with tissue ingrowth, particularly when using non-biodegradable materials that lack sufficient cellular attachment and integration.
Innovation Solution
The development of implantable medical devices with a substrate coated using click chemistry, which involves functionalizing the surface with reactive members that covalently bond chemotactic agents, promoting cell attachment, proliferation, and differentiation, thereby enhancing cellular ingrowth and integration.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Strength
If non-biodegradable materials are used for implantable medical devices, then device strength and structural support are improved, but cellular integration and tissue ingrowth are hindered
Solution Approach 1:
The patent applies local quality by functionalizing only the surface of the non-biodegradable device with reactive members, while the bulk material maintains its structural properties. This allows the device to simultaneously provide mechanical strength through the non-biodegradable substrate and promote cellular integration through the chemotactic coating on the surface.
Solution Approach 2:
The invention creates a composite structure combining non-biodegradable substrate material with a biologically active chemotactic coating. This composite approach allows the device to exhibit both the mechanical properties of non-biodegradable materials and the biological integration capabilities of bioactive surfaces.
2Stability of the object's composition
If surgical adhesives are used to fix mesh or patch, then fixation is improved, but tissue ingrowth is interfered with due to physical barrier formation
Solution Approach 1:
The patent removes the need for separate surgical adhesives by integrating fixation functionality directly into the device surface through chemotactic agents. The chemotactic coating promotes cellular attachment and tissue integration that naturally secures the device, eliminating the physical barrier problem associated with adhesive layers.
Solution Approach 2:
The chemotactic agents serve as intermediaries that facilitate direct interaction between the device surface and cells. Instead of using adhesives that create a barrier, the chemotactic coating mediates cellular attachment and tissue integration, allowing direct cellular contact with the device surface.
3Ease of manufacture
If conventional coating methods are used on implantable devices, then manufacturing simplicity is maintained, but controlled cellular response and chemotaxis are not achieved
Solution Approach 1:
The patent applies preliminary action by pre-functionalizing the device surface with reactive members before implantation. The chemotactic coating is prepared in advance with specific molecular structures that will selectively bind to cellular components, ensuring controlled cellular response upon implantation without requiring complex manufacturing processes.
Solution Approach 2:
The invention changes the chemical parameters of the device surface by introducing reactive members and chemotactic agents with specific functional groups. This allows control over cellular response through chemical affinity and specificity, while the coating process itself can be applied using relatively simple techniques.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach improves the integration of medical devices with tissue by attracting cells and guiding their growth, addressing the limitations of existing devices that struggle with cellular integration and tissue ingrowth.
Implementation Method 1
The surface of the substrate is functionalized with a first reactive member and a chemotactic agent is functionalized with a second reactive member. The first and second reactive members react to covalently bond the chemotactic agent to the surface of the substrate.
Implementation Method 2
The coating includes one or more chemotactic agents, which are useful for attracting cells, modulating cell attachment, guiding cellular ingrowth, including cell proliferation and/or differentiation.
Data Source
AI summary
A medical device includes a substrate having at least a portion thereof functionalized with at least one reactive member and a chemotactic agent functionalized with at least one complementary reactive member. The at least one reactive member and the at least one complementary reactive member are covalently bonded, adhering the chemotactic agent to the substrate.